Semen Indonesia (Persero) Tbk PT
IDX:SMGR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 240
6 500
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Semen Indonesia (Persero) Tbk PT
Semen Indonesia (Persero) Tbk PT
Additional Paid In Capital
Semen Indonesia (Persero) Tbk PT
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Semen Indonesia (Persero) Tbk PT
IDX:SMGR
|
Additional Paid In Capital
Rp6.2T
|
CAGR 3-Years
62%
|
CAGR 5-Years
34%
|
CAGR 10-Years
16%
|
|
|
Solusi Bangun Indonesia Tbk PT
IDX:SMCB
|
Additional Paid In Capital
Rp5T
|
CAGR 3-Years
0%
|
CAGR 5-Years
14%
|
CAGR 10-Years
7%
|
|
|
Indocement Tunggal Prakarsa Tbk PT
IDX:INTP
|
Additional Paid In Capital
Rp2.7T
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Semen Baturaja (Persero) Tbk PT
IDX:SMBR
|
Additional Paid In Capital
Rp1.3T
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Waskita Beton Precast Tbk PT
IDX:WSBP
|
Additional Paid In Capital
Rp4T
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Cemindo Gemilang Tbk PT
IDX:CMNT
|
Additional Paid In Capital
-Rp1.7T
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Semen Indonesia (Persero) Tbk PT
Glance View
Semen Indonesia (Persero) Tbk PT, the cornerstone of Indonesia's cement industry, traces its origins back to 1957. Initially launched as a state-owned enterprise, the company has evolved into a predominant entity in Southeast Asia, achieving widespread influence and a dominant market share across the region. As Indonesia embarked on its rapid modernization journey, the growing demand for infrastructure and residential projects created an insatiable appetite for cement, which Semen Indonesia was well-positioned to supply. By strategically acquiring domestic competitors and consolidating operations, the company expanded its production capabilities, diversifying its product range to include various types of cement and clinker, thereby solidifying its status as a leading conglomerate. Operating primarily through its subsidiaries, Semen Indonesia optimizes its revenue stream through the production and sale of these essential building materials. The company capitalizes on its extensive distribution network, serving both local and international markets. Maximizing operational efficiencies further drives its profitability, as does its commitment to sustainable practices aimed at reducing environmental impact and conserving energy. Through innovation and strategic partnerships, Semen Indonesia continually enhances its production methods and expands its market foothold. This steadfast commitment to growth and sustainability ensures that it remains a pivotal player in supporting the region's infrastructural development, while simultaneously securing its own financial durability.
See Also
What is Semen Indonesia (Persero) Tbk PT's Additional Paid In Capital?
Additional Paid In Capital
6.2T
IDR
Based on the financial report for Sep 30, 2024, Semen Indonesia (Persero) Tbk PT's Additional Paid In Capital amounts to 6.2T IDR.
What is Semen Indonesia (Persero) Tbk PT's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
16%
Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Semen Indonesia (Persero) Tbk PT have been 62% over the past three years , 34% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet